Our genetic tests are addressing unmet needs for the accurate diagnosis of diseases that involve large scale genome modifications.
Although large scale genome modifications are significant in human polymorphisms, cancer and genetic diseases, very few methods can detect them in a simple, reproducible and precise manner.
With a resolution ranging from 1 kilobase to 1 megabase, Molecular Combing is a relevant approach to screen whole genomes to detect qualitative and quantitative changes such as amplifications, deletions, insertions, repeated arrays and translocations.
Our diagnostics division specializes in the discovery of unique genomic biomarkers and their application in the development of novel genetic tests.
We are developing a pipeline of sensitive, reproducible and easy to use genetic tests.
The first available test is: